1![Health economics / B-cell chronic lymphocytic leukemia / Lymphocytic leukemia / Lymphoma / Orphan drugs / Leukemia / Chlorambucil / End point of clinical trials / Rituximab / Medicine / Oncology / Health Health economics / B-cell chronic lymphocytic leukemia / Lymphocytic leukemia / Lymphoma / Orphan drugs / Leukemia / Chlorambucil / End point of clinical trials / Rituximab / Medicine / Oncology / Health](/pdf-icon.png) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-04-22 23:39:46
|
---|
2![Microsoft Word - Roche 5-10 obinutuzumabPSD final.docx Microsoft Word - Roche 5-10 obinutuzumabPSD final.docx](https://www.pdfsearch.io/img/79a0b2eb9b30b5f1e18847c55722f52b.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-04-22 23:39:46
|
---|
3![1208±1215 Nucleic Acids Research, 2003, Vol. 31, No. 4 DOI: [removed]nar/gkg215 DNA crosslinking and biological activity of a hairpin polyamide±chlorambucil conjugate Yong-Dong Wang, Jaroslaw Dziegielewski, Nicholas R. 1208±1215 Nucleic Acids Research, 2003, Vol. 31, No. 4 DOI: [removed]nar/gkg215 DNA crosslinking and biological activity of a hairpin polyamide±chlorambucil conjugate Yong-Dong Wang, Jaroslaw Dziegielewski, Nicholas R.](https://www.pdfsearch.io/img/f17c1b4eb21d5a9ec591b71486d4ba1d.jpg) | Add to Reading ListSource URL: authors.library.caltech.eduLanguage: English - Date: 2012-12-26 03:45:20
|
---|
4![improvement in survival compared to chlorambucil, it offers patients another choice in first-line treatment for CLL, and has a manageable toxicity profile. pERC deliberated on the potential cost-effectiveness of obinut
improvement in survival compared to chlorambucil, it offers patients another choice in first-line treatment for CLL, and has a manageable toxicity profile. pERC deliberated on the potential cost-effectiveness of obinut](https://www.pdfsearch.io/img/0976ce24c85845b8fa656f4dadeb327b.jpg) | Add to Reading ListSource URL: www.pcodr.caLanguage: English - Date: 2015-01-09 16:20:37
|
---|
5![considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab + chlorambucil is not co
considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab + chlorambucil is not co](https://www.pdfsearch.io/img/ff309831197993863fe831b37c837510.jpg) | Add to Reading ListSource URL: www.pcodr.caLanguage: English - Date: 2014-12-04 16:10:34
|
---|
6![144 IARC MONOGRAPHS SUPPLEMENT 7 It did not induce chromosomal aberrations, unscheduled DN A synthesis or DN A strand breaks in cells of rodents treated in vivo. It did not induce chromosomal aberrations or sister 144 IARC MONOGRAPHS SUPPLEMENT 7 It did not induce chromosomal aberrations, unscheduled DN A synthesis or DN A strand breaks in cells of rodents treated in vivo. It did not induce chromosomal aberrations or sister](https://www.pdfsearch.io/img/73fb23be4bd0145563bb0862972aaa8c.jpg) | Add to Reading ListSource URL: monographs.iarc.frLanguage: English - Date: 2012-08-13 12:55:39
|
---|
7![CHLORAMPHENICOL 145 C. Other relevant data Chlorambucil is a bifunctional alkylating agent. It induced sister chromatid exchanges CHLORAMPHENICOL 145 C. Other relevant data Chlorambucil is a bifunctional alkylating agent. It induced sister chromatid exchanges](https://www.pdfsearch.io/img/71ff16de39c0c28cd096eb35403c8ec8.jpg) | Add to Reading ListSource URL: monographs.iarc.frLanguage: English - Date: 2012-08-13 12:55:39
|
---|
8![](https://www.pdfsearch.io/img/f1cfacc216bd9c88207bf866f6bf3c12.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2011-11-04 14:39:31
|
---|
9![Microsoft Word - Arzerra Data Backgrounder_FINAL Microsoft Word - Arzerra Data Backgrounder_FINAL](https://www.pdfsearch.io/img/4c9f1edd366112fbab4f40498aa99471.jpg) | Add to Reading ListSource URL: us.gsk.comLanguage: English |
---|
10![1 Part I Principles of Tumor Targeting Drug Delivery in Oncology: From Basic Research to Cancer Therapy, First Edition. 1 Part I Principles of Tumor Targeting Drug Delivery in Oncology: From Basic Research to Cancer Therapy, First Edition.](https://www.pdfsearch.io/img/d4ac0063c9f451d36a0df6be8eab01fe.jpg) | Add to Reading ListSource URL: www.wiley-vch.deLanguage: English - Date: 2011-12-07 21:04:36
|
---|